首页> 外文OA文献 >Screening of Clinically Approved and Investigation Drugs as Potential Inhibitors of COVID-19 Main Protease: A Virtual Drug Repurposing Study

【2h】

Screening of Clinically Approved and Investigation Drugs as Potential Inhibitors of COVID-19 Main Protease: A Virtual Drug Repurposing Study

机译：临床批准和调查药物作为Covid-19主要蛋白酶的潜在抑制剂：虚拟药物重新训练研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Serdar Durdagi; Busecan Aksoydan; Berna Dogan; Kader Sahin; Aida Shahraki;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Virtual screening and repurposing of FDA approved drugs against COVID-19 main protease [J] . Life sciences . 2020,第期

机译：FDA批准药物对Covid-19主要蛋白酶的虚拟筛选和重新估算
2. Structure-based virtual screening of phytochemicals and repurposing of FDA approved antiviral drugs unravels lead molecules as potential inhibitors of coronavirus 3C-like protease enzyme [J] . Arun Bahadur Gurung, Mohammad Ajmal Ali, Joongku Lee, Journal of King Saud University . 2020,第6期

机译：基于结构的虚拟筛选植物化学和FDA批准的抗病毒药物的重新筛选将铅分子解释为冠状病毒3C样蛋白酶酶的潜在抑制剂
3. In silico drug repurposing of FDA-approved drugs to predict new inhibitors for drug resistant T3151 mutant and wild-type BCR-ABL1: A virtual screening and molecular dynamics study [J] . Sohraby Farzin, Bagheri Milad, Aliyar Masoud, Journal of molecular graphics & modelling . 2017,第期

机译：在Silico批准的药物重新批准FDA批准的药物中，以预测耐药性T3151突变体和野生型BCR-ABL1的新抑制剂：虚拟筛选和分子动力学研究
4. Re-purposing FDA Approved Drugs: LC-HRMS Characterization of Metabolites of Drugs that Inhibit Cancer Cell Growth [C] . Samantha M. Mahmoud, Dil Ramanathan American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics . 2011

机译：重新介绍FDA批准的药物：LC-HRMS表征药物代谢物，抑制癌细胞生长
5. Identification of Licofelone Through Three-Dimensional Cell Culture Drug Screening as a Repurposed Agent Able to Reverse Drug Resistant and Cancer Stem Cell-like Subpopulations in Ovarian Cancer [D] . Hirst, Jeffrey J. 2017

机译：通过三维细胞培养药物筛选作为一种能够逆转卵巢癌的耐药性和癌症干细胞样亚群的改用药物，鉴定力费龙
6. Virtual screening and repurposing of FDA approved drugs against COVID-19 main protease [O] . Mahmoud Kandeel, Mohammed Al-Nazawi -1

机译：FDA批准的针对COVID-19主蛋白酶的药物的虚拟筛选和重新利用
7. Virtual screening and repurposing of FDA approved drugs against COVID-19 main protease [O] . Mahmoud Kandeel, Mohammed Al-Nazawi 2020

机译：FDA批准药物对Covid-19主要蛋白酶的虚拟筛选和重新估算
8. Third Party Payment for Unapproved Uses of Approved Drugs and for Medical Care Associated with Drug Clinical Trials [R] . Smith, E. S. 1991

机译：未经批准的药物使用和药物临床试验相关医疗的第三方付款

Screening of Clinically Approved and Investigation Drugs as Potential Inhibitors of COVID-19 Main Protease: A Virtual Drug Repurposing Study

著录项

引文网络

相似文献

相关主题

期刊订阅